Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$148.46
-0.2%
$163.82
$123.00
$257.40
$4.42B1.39580,779 shs365,308 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$278.18
+0.3%
$275.79
$148.00
$310.00
$10.76B0.56416,051 shs834,531 shs
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$26.54
+1.5%
$27.48
$23.69
$31.72
$11.60B0.71826,066 shs706,966 shs
Solventum Co. stock logo
SOLV
Solventum
$65.95
+1.6%
$72.87
$47.16
$85.92
$11.23BN/A1.31 million shs639,849 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-0.25%+1.11%-13.13%-20.71%-36.59%
Penumbra, Inc. stock logo
PEN
Penumbra
+0.83%-0.03%-2.77%+1.80%+35.24%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
+1.32%+3.23%-5.23%+6.27%+7.02%
Solventum Co. stock logo
SOLV
Solventum
+1.43%+0.38%-11.17%-10.39%+3.86%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.6684 of 5 stars
4.41.00.04.83.32.51.9
Penumbra, Inc. stock logo
PEN
Penumbra
4.0742 of 5 stars
2.43.00.03.73.42.51.9
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.4858 of 5 stars
1.04.02.50.03.20.03.1
Solventum Co. stock logo
SOLV
Solventum
1.5871 of 5 stars
3.04.00.00.02.70.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.70
Moderate Buy$218.9047.45% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$293.935.66% Upside
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.00
Hold$27.001.73% Upside
Solventum Co. stock logo
SOLV
Solventum
2.00
Hold$79.8621.09% Upside

Current Analyst Ratings Breakdown

Latest INSP, SOLV, SNN, and PEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/21/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$190.00 ➝ $175.00
4/21/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$234.00 ➝ $216.00
4/15/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$315.00
4/15/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$260.00 ➝ $215.00
4/11/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$325.00 ➝ $315.00
3/17/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$27.00 ➝ $27.00
3/14/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$320.00
3/12/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
3/5/2025
Solventum Co. stock logo
SOLV
Solventum
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$73.00 ➝ $80.00
3/3/2025
Solventum Co. stock logo
SOLV
Solventum
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$70.00 ➝ $82.00
3/3/2025
Solventum Co. stock logo
SOLV
Solventum
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$63.00 ➝ $71.00
(Data available from 4/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$802.80M5.50$1.42 per share104.41$23.25 per share6.39
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B9.01$2.65 per share105.01$29.88 per share9.31
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.81B2.00$3.32 per share8.00$11.94 per share2.22
Solventum Co. stock logo
SOLV
Solventum
$8.25B1.38N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$53.51M$1.7385.8146.102.866.67%8.19%7.09%5/5/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$90.95M$0.34818.1855.522.831.17%9.74%7.35%N/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263M$2.1612.2913.271.26N/AN/AN/AN/A
Solventum Co. stock logo
SOLV
Solventum
N/A$2.7523.9812.011.94N/AN/AN/A5/8/2025 (Estimated)

Latest INSP, SOLV, SNN, and PEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Solventum Co. stock logo
SOLV
Solventum
$1.19N/AN/AN/A$2.02 billionN/A
5/5/2025Q1 2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.23N/AN/AN/A$194.89 millionN/A
2/18/2025Q4 2024
Penumbra, Inc. stock logo
PEN
Penumbra
$0.88$0.97+$0.09$0.86$311.63 million$315.52 million
2/10/2025Q4 2024
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$0.74$1.15+$0.41$1.15$239.76 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.893.35%N/A41.20%N/A
Solventum Co. stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A

Latest INSP, SOLV, SNN, and PEN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
semi-annual$0.44702.5%3/28/20253/28/20255/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
7.13
6.22
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.01
3.25
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.63
2.51
1.11
Solventum Co. stock logo
SOLV
Solventum
2.45
1.15
0.83

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%
Solventum Co. stock logo
SOLV
Solventum
N/A

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.10%
Penumbra, Inc. stock logo
PEN
Penumbra
5.00%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%
Solventum Co. stock logo
SOLV
Solventum
0.05%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
76029.76 million28.45 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
3,90038.68 million36.59 millionOptionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
20,100437.20 million432.83 millionOptionable
Solventum Co. stock logo
SOLV
Solventum
22,000173.00 millionN/AOptionable

Recent News About These Companies

Analysts Set Solventum Co. (NYSE:SOLV) PT at $79.86
3M Earnings Will Be Scoured for Tariff Impacts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$148.46 -0.26 (-0.17%)
Closing price 04/23/2025 03:58 PM Eastern
Extended Trading
$148.38 -0.08 (-0.05%)
As of 04/23/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Penumbra stock logo

Penumbra NYSE:PEN

$278.18 +0.96 (+0.35%)
Closing price 04/23/2025 03:59 PM Eastern
Extended Trading
$280.00 +1.82 (+0.65%)
As of 07:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Smith & Nephew stock logo

Smith & Nephew NYSE:SNN

$26.54 +0.38 (+1.45%)
Closing price 04/23/2025 03:59 PM Eastern
Extended Trading
$25.97 -0.57 (-2.13%)
As of 04/23/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Solventum stock logo

Solventum NYSE:SOLV

$65.95 +1.01 (+1.56%)
Closing price 04/23/2025 03:59 PM Eastern
Extended Trading
$67.20 +1.25 (+1.90%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.